# Changes of Depression After First-year of Tofacitinib in RA Patients

> **NCT03992781** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 73 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03992781
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-23
- **Primary completion:** 2024-02-07
- **Final completion:** 2024-02-07
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2025-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03992781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03992781, "Changes of Depression After First-year of Tofacitinib in RA Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03992781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*